Patents by Inventor Kirsten Leineweber

Kirsten Leineweber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230151442
    Abstract: A lysis buffer comprising one non-ionic surfactant is provided which can be used as a one-step reagent of the preparation, storage, amplification, and/or detection of nucleic acids. Various embodiments of the lysis buffer of the invention comprise other substances that are compatible or useful in lysing cells, storing nucleic acids, amplifying nucleic acids, purifying nucleic acids, detecting nucleic acids, and/or other procedures for analysis of nucleic acids. Methods and kits based on the lysis buffer are also provided, including those for rapid lysis of cells and direct use of the resulting cell lysates in RT-PCR.
    Type: Application
    Filed: April 1, 2021
    Publication date: May 18, 2023
    Applicant: Bayer Aktiengesellschaft
    Inventors: Stefan GOLZ, Holger SUMMER, Silke AIGNER, Heidrun ELLINGER-ZIEGELBAUER, Kirsten LEINEWEBER, Thomas MÜLLER
  • Publication number: 20200339567
    Abstract: The present application relates to novel substituted imidazopyridine amides of the formula (I), to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prophylaxis of diseases and to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular, neurological and central nervous as well as metabolic disorders.
    Type: Application
    Filed: October 18, 2018
    Publication date: October 29, 2020
    Applicants: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft
    Inventors: Daniel MEIBOM, Jutta MEYER, Karl COLLINS, Nuria ORTEGA HERNANDEZ, Jan STAMPFUSS, Frank WUNDER, Till FREUDENBERGER, Thomas MONDRITZKI, Nina Alexandra SCHEERER, Kirsten LEINEWEBER, Jens SCHAMBERGER, Alexander STRAUB, Kersten Matthias GERICKE, Walter KROH, Mario LOBELL, Klaus MÜNTER
  • Publication number: 20160311812
    Abstract: The present application relates to selective partial adenosine A1 receptor agonists of the formula (I) and their use for treating and/or preventing diseases and to their use for preparing medicaments for treating and/or preventing diseases, preferably for treating and/or preventing acute and/or chronic kidney disorders (primary disorder and secondary disorder) with and without concomitant acute and/or chronic heart disorders.
    Type: Application
    Filed: December 9, 2014
    Publication date: October 27, 2016
    Applicant: Bayer Pharma Aktiengesellschaft
    Inventors: Barbara ALBRECHT-KÜPPER, Kirsten LEINEWEBER, Axel KRETSCHMER, Daniel MEIBOM, Alexandros VAKALOPOULOS, Nicole DIEDRICHS, Katja ZIMMERMANN
  • Patent number: 9382305
    Abstract: The present invention provides Relaxin fusion polypeptides A-L-B with a non-wild type array of the Relaxin A-chain and Relaxin B-chain, wherein the A- and B-chains are connected by a linker peptide. The invention further provides Relaxin fusion polypeptides with extended half-life. Furthermore, the invention provides nucleic acid sequences encoding the foregoing fusion polypeptides, vectors containing the same, pharmaceutical compositions and medical use of such fusion polypeptides.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: July 5, 2016
    Assignee: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Andreas Wilmen, Ulrich Haupts, Christoph Freiberg, Mark Trautwein, Lars Linden, Kirsten Leineweber, Hanna Tinel
  • Publication number: 20150329613
    Abstract: The present invention provides Relaxin fusion polypeptides with extended half-life. Thereby, the half-life extending parts are either the Fc moiety of the human IgG2 or of the human IgG4. Furthermore, the invention provides nucleic acid sequences encoding the foregoing fusion polypeptides, vectors containing the same, pharmaceutical compositions and medical use of such fusion polypeptides.
    Type: Application
    Filed: December 20, 2013
    Publication date: November 19, 2015
    Inventors: Andreas WILMEN, Kirsten LEINEWEBER, Nina Alexandra SCHEERER, Hannah JÖRIßEN
  • Publication number: 20140187491
    Abstract: The present invention provides Relaxin fusion polypeptides A-L-B with a non-wild type array of the Relaxin A-chain and Relaxin B-chain, wherein the A- and B-chains are connected by a linker peptide. The invention further provides Relaxin fusion polypeptides with extended half-life. Furthermore, the invention provides nucleic acid sequences encoding the foregoing fusion polypeptides, vectors containing the same, pharmaceutical compositions and medical use of such fusion polypeptides.
    Type: Application
    Filed: June 29, 2012
    Publication date: July 3, 2014
    Applicant: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Andreas Wilmen, Ulrich Haupts, Christoph Freiberg, Mark Trautwein, Lars Linden, Kirsten Leineweber, Hanna Tinel